Pre-analytic saliva processing affect proteomic results and biomarker screening of head and neck squamous carcinomta

International Journal of Oncology

Volumn 30, Issue 3, 2007, Pages 743-749

  Ohshiro, Kazufumi ^a   Rosenthal, David I ^a   Koomen, John M ^a   Streckfus, Charles F ^a   Chambers, Mark ^a   Kobayashi, Ryuji ^a   El Naggar, Adel K ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Biomarkers; Head and neck; Proteomics; Saliva; Squamous cell carcinoma

Indexed keywords

BIOLOGICAL MARKER; TUMOR MARKER;

ARTICLE; BIOSYNTHESIS; FEMALE; HEAD AND NECK TUMOR; HUMAN; LIQUID CHROMATOGRAPHY; MALE; MASS SCREENING; MASS SPECTROMETRY; METABOLISM; METHODOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEOMICS; SALIVA; SQUAMOUS CELL CARCINOMA;

BIOLOGICAL MARKERS; CARCINOMA, SQUAMOUS CELL; CHROMATOGRAPHY, LIQUID; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MASS SCREENING; MASS SPECTROMETRY; PROTEOMICS; SALIVA; TUMOR MARKERS, BIOLOGICAL;

EID: 33947732909     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Humphrey SP and Williamson RT: A review of saliva: normal composition, flow, and function. J Prosthet Dent 85: 162-169, 2001.
2. Amerongen AV and Veerman EC: Saliva - the defender of the oral cavity. Oral Dis 8: 12-22, 2002.
3. Van Nieuw AA, Bolscher JG and Veerman EC: Salivary proteins: protective and diagnostic value in cariology? Caries Res 38: 247-253, 2004.
4. Drake RR, Cazare LH, Semmes OJ and Wadsworth JT: Serum, salivary and tissue proteomics for discovery of biomarkers for head and cancers. Expert Rev Mol Diagn 5: 93-100, 2005.
5. El-Naggar AK, Mao L, Staerkel G, Coombes MM, Tucker SL, Luna MA, Clayman GL, Lippman S and Goepfert H: Genetic heterogeneity in saliva from patients with oral squamous carcinomas: implications in molecular diagnosis and screening. J Mol Diagn 3: 164-170, 2001.
6. Kaufman E and Lamster IB: Analysis of saliva for periodontal diagnosis - a review. J Clin Periodontol 27: 453-465, 2000.
7. Bellamy W, Takase M, Yamauchi K, Wakabayashi H, Kawase K and Tomita M: Identification of the bactericidal domain of lactoferrin. Biochim Biophys Acta 112: 130-136, 1992.
8. Blankenvoorde MF, van't Hof W, Walgreen-Weterings E, van Steenbergen TJ, Brand HS, Nieuw Amerongen AV and Veerman EC: Cystatin and cystatin-derived peptides have antibacterial activity against the pathogen Porphyromonas gingivalis. Biol Chem 379: 1371-1375, 1998.
9. Dale BA and Krisanaprakornkit S: Defensin antimicrobial peptides in the oral cavity. J Oral Pathol Med 30: 321-327, 2001.
10. Dowd FJ: Saliva and dental caries. Dent Clin North Am 43: 457-597, 1999.
11. Ericson T and Rundegren J: Characterization of a salivary agglutinin reacting with a serotype c strain of Streptococcus mutans. Eur J Biochem 133: 255-261, 1983.
12. Henskens YM, Veerman EC and Nieuw Amerongen AV: Cystatins in health and disease. Biol Chem Hoppe Seyler 377: 71-86, 1996.
13. Lamont RJ, Demuth DR, Davis CA, Malamud D and Rosan B: Salivary-agglutinin-mediated adherence of Streptococcus mutans to early plaque bacteria. Infect Immun 59: 3446-3450, 1991.
14. Mackay BJ, Denepitiya L, Iacona VJ, Krost SB and Pollock JJ: Growth-inhibitory and bactericidal effects of human parotid salivary histidine-rich polypeptides on Streptococcus mutans. Infect Immun 44: 695-701, 1984. (Pubitemid 14112703)
15. Mathews M, Jia HP, Guthmiller JM, Losh G, Graham S, Johnson GK, Tack BF and McCray PB Jr: Production of beta-defensin antimicrobial peptides by the oral mucosa and salivary gland. Infect Immun 67: 2740-2745,1999.
16. McNabb PC and Tomasi TB: Host defense mechanisms at mucosal surfaces. Annu Rev Microbiol 35: 477-496, 1981.
17. Oppenheim FG, Xu T, McMilliam FM, Levitz SM, Diamond RD, Offner GD and Troxler RF: Histatins, a novel family of histidine-rich proteins in human parotid secretion. Isolation, characterization, primary structure, and fungistatic effects on Candida albicans. J Biol Chem 263: 7472-7477, 1988.
18. Pollock JJ, Lotardo S, Gavai R and Grossbard BL: Lysozyme-protease- inorganic monovalent anion lysis of oral bacterial strains in buffers and stimulated whole saliva. J Dent Res 66: 467-474, 1987.
19. Slomiany BL, Murty VL, Piotrowski J and Slomiany A: Salivary mucins in oral mucosal defense. Gen Pharmacol 27: 761-771, 1996. (Pubitemid 26295632)
20. Tabak LA: Structure and function of human salivary mucins. Crit Rev Oral Biol Med 1: 229-234, 1990.
21. Tenovuo J, Lumikari M and Soukka T: Salivary lysozyme, lactoferrin and peroxidases: antibacterial effects on cariogenic bacteria and clinical applications in preventive dentistry. Proc Finn Dent Soc 87: 197-208, 1991.
22. Caprioli RM: Deciphering protein molecular signatures in cancer tissues to aid in diagnosis, prognosis, and therapy. Cancer Res 65: 10642-10645, 2005.
23. Yarbrough WG, Slebos RJC and Liebler D: Proteomics: clinical applications for head and neck squamous cell carcinoma. Head Neck 26: 549-558, 2006. (Pubitemid 43846224)
24. Hardt M, Thomas LR, Dixon SE, Newport G, Agabian N, Prakobphol A, Hall SC, Witkowska HE and Fisher SJ: Toward defining the human parotid gland salivary proteome and peptidome: Identification and characterization using 2D SDS-PAGE, ultrafiltration, HPLC, and mass spectrometry. Biochemistry 44: 2885-2899, 2005.
25. Hu S, Xie Y, Ramachandran P, Ogorzalek Loo RR, Li Y, Loo JA and Wong DT: Large-scale identification of proteins in human salivary proteome by liquid chromatography/mass spectrometry and two-dimensional gel electrophoresis-mass spectrometry. Proteomics 5: 1714-1728, 2005.
26. Huang CM: Comparative proteomic analysis of human whole saliva. Arch Oral Biol 49: 951-962, 2004. (Pubitemid 39366832)
27. Vitorino R, Lobo MJ, Ferrer-Correira AJ, Dubin JR, Tomer KB, Domingues PM and Amado FM: Identification of human whole saliva protein components using proteomics. Proteomics 4: 1109-1115, 2004.
28. Wilmarth PA, Riviere MA, Rustvold DL, Lauten JD, Madden TE and David LL: Two-demensional liquid chromatography study of the human whole saliva proteome. J Proteome Res 3: 1017-1023, 2004.
29. Xie H, Rhodus NL, Griffin RJ, Carlis JV and Griffin TJ: A catalogue of human saliva proteins identified by free flow electrophoresis-based peptide separation and tandem mass spectrometry. Mol Cell Proteomics 4: 1826-1830, 2005.
30. Andoh A, Fujiyama Y, Bamba T and Hosoda S: Differential cytokine regulation of complement C3, C4, and factor B synthesis in human intestinal epithelial cell line, Caco-2. J Immunol 151: 4239-4247, 1993.
31. Morris KM, Aden DP, Knowles BB and Colten HR: Complement biosynthesis by the human hepatoma-derived cell line HepG2. J Clin Invest 70: 906-913, 1982. (Pubitemid 12038107)
32. Yancey KB, Overholser O, Domloge-Hultsch N, Li LJ, Caughman SW and Bisalbutra P: Human keratinocytes and A-431 cells synthesize and secrete factor B, the major zymogen protease of the alternative complement pathway. J Invest Dermatol 98: 379-383, 1992.
33. Kolb WP, Morrow PR and Tamerius JD: Ba and Bb fragments of factor B activation: fragment production, biological activities, neoepitope expression and quantitation in clinical samples. Complement Inflamm 6: 175-204, 1989.
34. Perlmutter DH and Colten HR: Molecular immunobiology of complement biosynthesis: a model of single-cell control of effector-inhibitor balance. Annu Rev Immunol 4: 231-251, 1986.
35. Watanable I, Horiuchi T and Fujita S: Role of protein kinase C activation in synthesis of complement components C2 and factor B in interferon-gamma- stimulated human fibroblasts, glioblastoma cell line A172 and monocytes. Biochem J 305: 425-431, 1995.
36. Barnum SR, Ishii Y, Agrawal A and Volanakis JE: Production and interferon-gamma-mediated regulation of complement component C2 and factors B and D by the astroglioma cell line U105-MG. Biochem J 287: 595-601, 1992.
37. Falus A, Rokita H, Walcz E, Brozik M, Hidvegi T and Meretey K: Hormonal regulation of complement biosynthesis in human cell lines-II. Upregulation of the biosynthesis of complement components C3, factor B and C1 inhibitor by interleukin-6 and interleukin-1 in human hepatoma cell line. Mol Immunol 27: 197-201, 1990.
38. Doustjalai SR, Yusof R, Yip CH, Looi LM, Pillay B and Hashim OH: Aberrant expression of acute-phase reactant proteins in sera and breast lesions of patients with malignant and benign breast tumors. Electrophoresis 25: 2392-2401, 2004.
39. Uwai M, Terui Y, Mishima Y, Tomizuka H, Ikeda M, Itoh T, Mori M, Ueda M, Inoue R, Yamada M, Hayasawa H, Horiuchi T, Niho Y, Matsumoto M, Ishizaka Y, Ikeda K, Ozawa K and Hatake K: A new apoptotic pathway for the complement factor B-derived fragment Bb. J Cell Physiol 195: 280-292, 2000.
40. Andoh A, Fujiyama Y, Kumra T, Uchihara H, Sakumoto H, Okabe H and Bamba T: Molecular characterization of complement components (C3, C4, and factor B) in human saliva. J Clin Immunol 17: 404-407, 1997. (Pubitemid 27431980)
41. Juneja RK, Saha N, Tay JS, Low PS and Gahne B: Distribution of plasma alpha-1-B-glycoprotein (A1BG) polymorphism in several populations of the Indian subcontinent. Ann Hum Biol 21: 443-448, 1994. (Pubitemid 2115025)
42. Udby L, Sorensen OE, Pass J, Johnsen AH, Behrendt N, Borregaard N and Kjeldsen L: Cysteine-rich secretory protein 2 is a ligand of alpha-1-B-glycoprotein human plams. Biochemistry 43: 12877-12886, 2004.